Monopar Therapeutics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Monopar Therapeutics Inc. (MNPR) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$44.11 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2021-11-12
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-09-30 was -$11.24K, a 114.67% decline year-over-year.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-06-30 was -$84.75K.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2021-03-31 was $51.88K, a 23.27% increase year-over-year.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2020-12-31 was $49.44K.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $3.79K.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2019 was -$9.14K, a 338.02% decline from fiscal 2018.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $3.84K, a 96.97% decline from fiscal 2017.
- Monopar Therapeutics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $126.78K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$11.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$95.99K derived: sum of 2 quarters · filed 2021-11-12 | -$44.11K 10-Q · filed 2021-11-12 | $5.33K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2021-06-30 | -$84.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$32.88K 10-Q · filed 2021-08-12 | $16.56K derived: sum of 3 quarters · filed 2021-08-12 | $93.17K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2021-03-31 | $51.88K 10-Q · filed 2021-05-13 | $101.32K derived: sum of 2 quarters · filed 2021-05-13 | $177.93K derived: sum of 3 quarters · filed 2021-11-12 | $13.58K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-12-31 | $49.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $126.05K derived: sum of 2 quarters · filed 2021-11-12 | -$38.30K derived: sum of 3 quarters · filed 2021-11-12 | $3.79K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $76.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$87.73K derived: sum of 2 quarters · filed 2021-11-12 | -$45.65K 10-Q · filed 2021-11-12 | $45.65K 10-Q · filed 2020-11-12 | -$59.42K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$164.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$122.26K 10-Q · filed 2021-08-12 | $122.26K 10-Q · filed 2020-08-06 | -$136.03K derived: sum of 3 quarters · filed 2021-08-12 | -$145.30K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $42.08K 10-Q · filed 2021-05-13 | $28.31K derived: sum of 2 quarters · filed 2021-05-13 | $19.04K derived: sum of 3 quarters · filed 2021-05-13 | $11.58K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | -$13.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$23.04K derived: sum of 2 quarters · filed 2021-03-25 | -$30.50K derived: sum of 3 quarters · filed 2021-03-25 | -$9.14K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$9.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$16.73K derived: sum of 2 quarters · filed 2020-11-12 | $4.63K 10-Q · filed 2020-11-12 | $4.63K 10-Q · filed 2019-11-12 | -$111.70K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$7.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $13.90K 10-Q · filed 2020-08-06 | -$102.43K derived: sum of 3 quarters · filed 2020-08-06 | -$61.05K derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-31 | $21.36K 10-Q · filed 2020-05-07 | -$94.97K derived: sum of 2 quarters · filed 2020-05-07 | -$53.59K derived: sum of 3 quarters · filed 2020-05-07 | -$553.00 derived: sum of 4 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$116.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$74.95K derived: sum of 2 quarters · filed 2020-03-27 | -$21.92K derived: sum of 3 quarters · filed 2020-03-27 | $3.84K 10-K · filed 2020-03-27 | $273.37K 10-K · filed 2019-02-26 | ||
| 2018-09-30 | $41.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $94.41K derived: sum of 2 quarters · filed 2019-11-12 | $120.17K 10-Q · filed 2019-11-12 | $259.73K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $53.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $78.80K 10-Q · filed 2019-08-08 | $218.35K derived: sum of 3 quarters · filed 2019-08-08 | $216.65K derived: sum of 4 quarters · filed 2019-08-08 | |||
| 2018-03-31 | $25.76K 10-Q · filed 2019-05-10 | $165.31K derived: sum of 2 quarters · filed 2019-05-10 | $163.61K derived: sum of 3 quarters · filed 2019-05-10 | $160.11K derived: sum of 4 quarters · filed 2019-05-10 | |||
| 2017-12-31 | $139.56K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $137.85K derived: sum of 2 quarters · filed 2019-02-26 | $134.35K derived: sum of 3 quarters · filed 2019-02-26 | $126.78K 10-K · filed 2019-02-26 | |||
| 2017-09-30 | -$1.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$5.21K derived: sum of 2 quarters · filed 2018-11-09 | -$12.78K 10-Q · filed 2018-11-09 | ||||
| 2017-06-30 | -$3.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$11.07K 10-Q · filed 2018-08-09 | |||||
| 2017-03-31 | -$7.57K 10-Q · filed 2018-05-11 | ||||||
| 2016-12-31 | -$298.00 10-K · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |